Primary pulmonary hypertension is a rare disease process, documented in only 17 of 10,000 autopsies.' For some obscure reason, it is restricted mostly to young women whose mean age at symptom onset is 22 years. Its diagnosis implies an ominous prognosis: The average length of life following diagnosis is 3 to 7 years.1,2 It is a diagnosis of exclusion necessitating the ruling out of all primary cardiopulmonary causes of pulmonary hypertension. The following case report is representative of the clinical and diagnostic evaluation of a patient with this disease.
Case Report
History. The patient is a 28-year-old gravida II, para II white woman who presented with a history of 3 months shortness of breath and postural lightheadedness. She had also noticed weakness and fatigue over this period and had several episodes suggesting paroxysmal nocturnal dyspnea. Her last pregnancy was uncomplicated and the baby was delivered normally 6 months before the onset of symptoms. She denied any history of rheumatic fever or heart disease in infancy or childhood.
The patient had experienced two epi-sodes of 1l0n-exertional1y-related substernal chest pain. She had a history of hypothyroidism and had been taking 0.2 mg of Synthroid for 6 years. A euthyroid state was suggested by history and confirmed by thyroid function tests. She had taken contraceptive tablets for a brief time several years before the onset of her symptoms. There was no history of skin rashes, abnormal reaction to sunlight, or allergy. The patient was a nonsmoker and denied any chronic cough or hemoptysis.
Evaluation before her transfer to Allegheny General Hospital had included a negative chest x-ray and a perfusion-ventilation lung scan.
On physical examination her blood pressure was 112/70, pulse 90/minute, and respirations 16 (Figure 1 ) showed right axis deviation and T wave changes throughout the precordial leads. The chest x-ray ( Figure 2 ) showed a prominent main pulmonary artery. The echocardiogram ( Figure 3A ) showed a diminished slope of the pulmonary valve with diminution of the a dip. The mitral valve echogram ( Figure 3B ) showed a diminished diastolic slope with otherwise normal appearing valve motion and thickness. Table 1 lists the hemodynamic data from the right and left heart catheterizations. The left ventriculogram suggested, mild left ventricular dysfunction with early hypokinesis and borderline ejection fraction, with no segmental contractile abnormality. Coronary angiograms showed normal coronary anatomy w!th no atherosclerotic process. Cineangiography of the left atrium and ventricle in the LAO position showed intact septum and no evidence in intracardiac shunts.
Pulmonary artery pressures were significantly elevated with no valvular or subvalvular gradients.
Discussion
Pathophysiology of Pulmonary Hypertension. The search for the genesis of pulmonary hypertension necessitates a reflection back into the in utero state. The fetal lung is unexpanded with high vascular resistance and low pulmonary blood flow. Histologically, there are thick muscular media of small pulmonary arteries. Immediately after delivery, the pulmonary vascular resistance decreases significantly as the lungs expand and the alveoli are aerated. The pulmonary blood flow rapidly increases as the ductus arteriosus closes over the first several days after delivery, at which time the pulmonary artery pressure decreases below that of the aortic pressure. The histologic changes of thinning of the vessels and decrease in the muscular media progress more slowly over a period of I to 11/2 years, resulting in the normal adult vessel structure. This involutional process in the pulmonary vasculature may be retarded if pulmonary blood flow increases from birth, as it does in congenital heart diseases that involve a left-to-right shunt. In such cases, the hypertrophy of the vessels may persist and increase the pulmonary artery resistance.
Vasoconstriction, which frequently accompanies the increase in pulmonary flow, can further increase the vascular resistance and contribute to the perpetuating of the pulmonary hypertension.
Several pathologic factors may be responsible for elevation of the pulmonary artery pressure (Figure 4 ). The major factors are ( 1 ) an increase in pulmonary capillary and/or left atrial pressure; (2) a decrease in the cross-sectional area of the total pulmonary vascular bed (this may be an actual decrease secondary to vascular obliteration or a &dquo;functional&dquo; decrease secondary to vasoconstriction from alveolar hypoxia); (3) alone does not appear to be fully responsible for causing or sustaining pulmonary pressure elevations. This is exemplified by some patients with atrial septal defect who, in spite of significant pulmonaryto-systemic flow ratios, maintain relatively normal pulmonary pressures far into adult life.
A reactive pulmonary vasculature with pulmonary vasoconstriction appears to play an important role in the evolution of pulmonary hypertension when associated with many diseases which increase resistance to left ventricular filling, as well as with mitral stenosis and other causes of high-grade elevation of pulmonary venous pressure. An exception of this is pulmonary hypertension from constrictive pericarditis, myocardial fibrosis, and restrictive endo-carditis in which there is usually no associated vasoconstriction. It is known that pulmonary vessels react to hypoxia and hypercapnea with profound vasoconstriction which is the paradoxical effect which such blood gas changes have upon the peripheral vessels ( Figure 5 ). This would appear to be a major contributing factor to the pulmonary hypertension that accompanies chronic pulmonary diseases or alveolar hypoventilation and hypoxia.
The postulated mechanisms responsible for creating pulmonary hypertension are schematically shown in Fig The elevated pulmonary pressure and resistence, in combination with vasoconstriction, eventually create permanent and progressive histologic changes which result in significant reduction of the lumen of the small pulmonary vessels (Figure 6 ). At this point in the natural history of the disease, relief of the stimulating &dquo;factors&dquo; is no longer capable of relieving the pulmonary hypertension or preventing the progression of the adverse hemodynamic sequelae. Di,fferential Diagnosis. This case exemplifies the exhaustive diagnostic requirements necessary to make a diagnosis of primary pulmonary hypertension. Since it is a diagnosis of exclusion, it necessitates ruling out the entire spectrum of cardiac and pulmonary disease processes that can cause secondary elevation of the pulmonary vascular pressure and resistance. The differential diagnosis must include (1) pulmonary parenchymal diseases, (2) systemic collagen diseases including SLE, scleroderma, and CREST syndrome with secondary pulmonary interstitial disease, (3) left heart disease, the most frequent being mitral stenosis, (4) intracardiac shunts including atrial septal defect, ventricular septal defect, and patent ductus arteriosus, (5) veno-occlusive disease, and (6) recurrent pulmonary emboli.
Pulmonary disease can usually be ruled out by the lack of historical and clinical findings that would indicate overt pul- intracardiac shunts are not difficult to exclude, provided that proper attention is given to clinical history, physical findings, and cardiovascular diagnostic studies. Diagnostic Studies. Echocardiographic and radioisotope scanning are gaining popularity as useful and informative noninvasive diagnostic tools in the differentiation of pulmonary hypertension. The echographic criteria for pulmonary hypertension have been well described.9.1° They include diminution or loss of the premature posterior movement toward opening of the pulmonic valve commensurate with atrial systole (a dip), accelerated rate of opening of the pulmonic valve with flattening of the diastolic slope, as well as increased right ventricular size. Unfortunately, echo vi-sualization of the pulmonic valve is not always technically possible, and the findings do not aid in the differential diagnosis of pulmonary hypertension. Other criteria, however, may be extremely valvuable in ruling out primary cardiac disease, but they must be interpreted with caution since many pitfalls of diagnosis are inherent in the echogram in patients with pulmonary hypertension. These include the abnormal EF diastolic slope of the mitral valve which can mimic that seen in mitral stenosis.
This decrease is thought to be due to a diminished rate of left ventricular filling.' However, preservation of a wave, lack of thickening or calcification of the mitral valve, and recognition of the movement of the posterior leaflet of the mitral valve opposite the anterior should readily exclude the diagnosis of mitral stenosis.
Another possible echo misinterpretation may result from asymmetric thickness of the septum in relation to the posterior ventricular wall, thus suggesting the possibility of IHSS. Paradoxical septal motion, usually attributed to right ventricular diastolic volume overload, has been identified in primary pulmonary hypertension and may result in serious consideration of an atrial or ventricular septal defect. Prolapse of the mitral valve leaflets has also been associated with pulmonary hypertension and may be related to associated connective tissue disorders. In our patient the echocardiogram ( Figure 3 ) showed many of the features mentioned above. Dyspnea on exertion and fatigue are the usual presenting symptoms and are most likely secondary to restricted cardiac output in response to exercise. The etiology of the syncope is most likely a response to the same limitation of cardiac reserve. The chest pain may represent a relative myocardial ischemia secondary to right heart hypertension, reduction of cardiac output, and fall in systemic blood pressure. Another possible cause of the chest pain is distension of the pulmonary artery accompanying the rise in pulmonary pressure on exercise. ' There is usually a paucity of physical findings early in the disease. Auscultatory abnormalities include an exaggerated P2 and a right ventricular S4 or S3 gallop. A prominent venous a wave may be appreciated. Advanced states of pulmonary hypertension may be accom-FIG. 7. Significant change in the electrocardiogram is correlated with considerable deterioration in hemodynamic status, as illustrated by an increase in the pulmonary artery pressure and resistance and a substantial decrease in the resting cardiac output. (A) Initial electrocardiogram of a patient with documented pulmonary hypertension. Hemodynamic data at time of electrocardiography: (1 ) pulmonary artery pressure 75/34 (48 mm Hg); (2) Pulmonary vascular resistance 496 dynes/sec/cm-6; (3) cardiac output 6.3 L/minute. (B) Electrocardiogram of the same patient 11/2 years later shows a dramatic change, with right axis deviation and solid criteria for right ventricular hypertrophy with associated ST-T wave changes. Hemodynamic data at time of electrocardiography: (I) pulmonary artery pressure 105/50 (75 mm Hg); (2) pulmonary vascular resistance 1510 dynes/sec/cm-1; (3) cardiac output 3.5 L/minute. Table 2 Symptoms of Primary Pulmonary Hypertension panied by a right ventricular heave and by murmurs of tricuspid insufficiency or a pulmonic ejection &dquo;flow&dquo; murmur. Cyanosis is a common but late manifestation and it may be caused by several factors.&dquo;
Electrocardiography usually demonstrates right axis deviation and right ven
Etiology. The etiology of primary pulmonary hypertension remains obscure in spite of numerous investigations. Theoretical possibilities are listed in Table  3 16-21 The most seriously considered cause is multiple micropulmonary emboli with resultant obliterative pulmonary arterial disease. There is little doubt that repetitive pulmonary emboli can result in established pulmonary hypertension, but this is rarely &dquo;silent&dquo; and can almost always be diagnosed by clinical history and physical findings, combined with ECG radiography, or pulmonary arteriography. There is little evidence to substantiate that a patient can have microemboli without symptoms long enough to cause established severe pulmonary hypertension. There is evidence, however, that in situ pulmonary arterial thrombosis may occur as a secondary phenomenom of primary pulmonary hypertension and may exacerbate the already established pulmonary pressure elevation and be responsible for rapid clinical deterioration.
Histologic studies have defined pulmonary arterial changes of atherosclerosis, medial hypertrophy, necrosis, intimal fibrosis, and thrombus formation together with dilated thin-walled arteries.16,21 These changes are not specific and have not helped in resolving the issue of the thromboembolic theory. The effect of long-term anticoagqlation on the natural progression of disease also appears to be still unresolved.
Some authors have considered the disease to be predetermined at conception. They postulate that abnormalities of pulmonary vasculature and resistance are either inherited or fostered in utero, and that the disease progresses silently until its clinical manifestation in the second or third decade.14 A case of familial pulmonary hypertension was thought to be caused by an inherited abnormal fibrinolysis that impaired the ability to lyse micropulmonary emboli.22 There has also been speculation that pulmonary hypertension develops in response to certain blood components, and that such agents cause release of a vasoactive substance such as histamine, serotonin, or noradrenalin.20
Others have seriously contemplated abnormal vasomotor response, basing their belief on the lability of pulmonary vasoconstriction noted in normal individuals during altitude changes as well as Clinical Course and Treatment. The clinical course of primary pulmonary hypertension is usually more malignant than pulmonary hypertension from secondary causes. Although there are reports of patients with this disease living up to 25 years after diagnosis.13.25 rapid deterioration is usually followed by death within 2 to 5 years. Death may be caused by progressive right ventricular failure, and a large part of sudden death may be due to arrhythmia or a sudden drop of cardiac output. There is an isolated report of spontaneous regression of primary hypertension in a young woman.26
The treatment of primary pulmonary hypertension has been as frustrating as the efforts to describe its etiology. At this time there is no therapy that can predictably alter the destructive progression or the fatal outcome. Various therapeutic agents-including ganglionic blockers, diuretics, reserpine, and steroids, and vasodilators including nitrates, isoporteranol, and oxygen therapy-have failed to produce any sustained reduction of pulmonary pressure or in any way to influence the course of deterioration. Although nitroglycerine in our patients resulted in a slight reduction of the mean PA pressure, the significance of this finding in view of existing data is speculative. However, we did elect to place her on maintenance nitroglycerine (Nitrobid) and suggested anticoagulation with Coumadin. Digitalis has also had no beneficial effect, and its use should be reserved for treatment of overt right or left heart failure.
A ddendum
Since submitting this manuscript for publication the reported patient has died. Autopsy lung specimens showed diffuse histologic changes of medial hypertrophy, intimal proliferation and fibrosis, and thrombosis of the small pulmonary arteries with partial and complete lumen obliteration. The changes are consistent with the clinical diagnosis of primary pulmonary hyper- 
